Aspen Pharmacare Holdings Limited (JSE:APN)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 15,105
+397 (2.70%)
Jul 10, 2026, 5:00 PM SAST
Aspen Pharmacare Holdings Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Aspen Pharmacare Holdings stock has a consensus rating of "Buy" and an average price target of ZAC 15,050. The average 1-year stock price forecast is 0.36% lower than the current stock price, while the lowest is ZAC 13,600 (-9.96%) and the highest is ZAC 17,500 (+15.86%).
Price Target: ZAC 15,050 (-0.36%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Aspen Pharmacare Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 2 | 2 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 3 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
37.98B
from 43.36B
Decreased by -12.41%
Revenue Next Year
39.01B
from 37.98B
Increased by 2.70%
EPS This Year
7.71
from 10.56
Decreased by -27.00%
EPS Next Year
12.28
from 7.71
Increased by 59.30%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is ZAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 42.7B | ||
| Avg | 38.0B | ||
| Low | 35.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.6% | ||
| Avg | -12.4% | ||
| Low | -17.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.40 | ||
| Avg | 7.71 | ||
| Low | 7.14 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -20.4% | ||
| Avg | -27.0% | ||
| Low | -32.4% |